Literature DB >> 18310261

Managing uninvestigated dyspepsia in primary care.

Naoki Chiba.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18310261      PMCID： PMC2270980          DOI： 10.1136/bmj.39497.622720.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Eradication of Helicobacter pylori for non-ulcer dyspepsia.

Authors:  P Moayyedi; S Soo; J Deeks; B Delaney; A Harris; M Innes; R Oakes; S Wilson; A Roalfe; C Bennett; D Forman
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 2.  American gastroenterological association technical review on the evaluation of dyspepsia.

Authors:  Nicholas J Talley; Nimish B Vakil; Paul Moayyedi
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

3.  Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.

Authors:  D Armstrong; S J O Veldhuyzen van Zanten; A N Barkun; N Chiba; A B R Thomson; S Smyth; P Sinclair; B Chakraborty; R J White
Journal:  Aliment Pharmacol Ther       Date:  2005-05-15       Impact factor: 8.171

4.  An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

Authors:  S J Veldhuyzen van Zanten; N Flook; N Chiba; D Armstrong; A Barkun; M Bradette; A Thomson; F Bursey; P Blackshaw; D Frail; P Sinclair
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

5.  Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis.

Authors:  Alexander C Ford; Michelle Qume; Paul Moayyedi; Nicolaas L A Arents; Annmarie T Lassen; Richard F A Logan; Kenneth E L McColl; Paul Myres; Brendan C Delaney
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

6.  A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.

Authors:  Sander J O Veldhuyzen van Zanten; Naoki Chiba; David Armstrong; Alan Barkun; Alan Thomson; Sandra Smyth; Sergio Escobedo; Joanna Lee; Paul Sinclair
Journal:  Am J Gastroenterol       Date:  2005-07       Impact factor: 10.864

7.  Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.

Authors:  Naoki Chiba; Sander J O Veldhuyzen Van Zanten; Paul Sinclair; Ralph A Ferguson; Sergio Escobedo; Eileen Grace
Journal:  BMJ       Date:  2002-04-27

8.  The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study.

Authors:  A B R Thomson; A N Barkun; D Armstrong; N Chiba; R J White; S Daniels; S Escobedo; B Chakraborty; P Sinclair; S J O Veldhuyzen Van Zanten
Journal:  Aliment Pharmacol Ther       Date:  2003-06-15       Impact factor: 8.171

9.  Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).

Authors:  Brendan C Delaney; Michelle Qume; Paul Moayyedi; Richard F A Logan; Alexander C Ford; Cathy Elliott; Cliodna McNulty; Sue Wilson; F D Richard Hobbs
Journal:  BMJ       Date:  2008-02-29

10.  Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.

Authors:  N Chiba; S J O Veldhuyzen Van Zanten; S Escobedo; E Grace; J Lee; P Sinclair; A Barkun; D Armstrong; A B R Thomson
Journal:  Aliment Pharmacol Ther       Date:  2004-02-01       Impact factor: 8.171
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.